PortalPublikationen[Immunoglobulins in primary antibody deficiency: should they...

[Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]

Standard

[Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]. / Kluge, Stefan; de Heer, Geraldine; Nierhaus, Axel; Kreymann, G.

in: INTERNIST, Jahrgang 48, Nr. 11, 11, 2007, S. 1297-1302, 1304.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kluge, S, de Heer, G, Nierhaus, A & Kreymann, G 2007, '[Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]', INTERNIST, Jg. 48, Nr. 11, 11, S. 1297-1302, 1304. <http://www.ncbi.nlm.nih.gov/pubmed/17901939?dopt=Citation>

APA

Kluge, S., de Heer, G., Nierhaus, A., & Kreymann, G. (2007). [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]. INTERNIST, 48(11), 1297-1302, 1304. [11]. http://www.ncbi.nlm.nih.gov/pubmed/17901939?dopt=Citation

Vancouver

Kluge S, de Heer G, Nierhaus A, Kreymann G. [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]. INTERNIST. 2007;48(11):1297-1302, 1304. 11.

Bibtex

@article{89d0e776d951429383f316daacc9359a,
title = "[Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]",
abstract = "Immunoglobulin is a blood product prepared from the plasma of healthy donors. The therapeutic use of polyvalent immunoglobulins is an established therapy in primary antibody deficiencies, in idiopathic thrombocytopenic purpura (ITP) and in Guillain-Barr{\'e} syndrome. However, there is an ongoing debate about the efficacy of polyvalent immunoglobulins as adjunctive therapy for sepsis. The paper presented here critically discusses the modern studies investigating the use of immunoglobulins in different diseases. The main focus is the use of immunoglobulins in patients with sepsis or septic shock.",
author = "Stefan Kluge and {de Heer}, Geraldine and Axel Nierhaus and G Kreymann",
year = "2007",
language = "Deutsch",
volume = "48",
pages = "1297--1302, 1304",
journal = "INTERNIST",
issn = "0020-9554",
publisher = "Springer",
number = "11",

}

RIS

TY - JOUR

T1 - [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?]

AU - Kluge, Stefan

AU - de Heer, Geraldine

AU - Nierhaus, Axel

AU - Kreymann, G

PY - 2007

Y1 - 2007

N2 - Immunoglobulin is a blood product prepared from the plasma of healthy donors. The therapeutic use of polyvalent immunoglobulins is an established therapy in primary antibody deficiencies, in idiopathic thrombocytopenic purpura (ITP) and in Guillain-Barré syndrome. However, there is an ongoing debate about the efficacy of polyvalent immunoglobulins as adjunctive therapy for sepsis. The paper presented here critically discusses the modern studies investigating the use of immunoglobulins in different diseases. The main focus is the use of immunoglobulins in patients with sepsis or septic shock.

AB - Immunoglobulin is a blood product prepared from the plasma of healthy donors. The therapeutic use of polyvalent immunoglobulins is an established therapy in primary antibody deficiencies, in idiopathic thrombocytopenic purpura (ITP) and in Guillain-Barré syndrome. However, there is an ongoing debate about the efficacy of polyvalent immunoglobulins as adjunctive therapy for sepsis. The paper presented here critically discusses the modern studies investigating the use of immunoglobulins in different diseases. The main focus is the use of immunoglobulins in patients with sepsis or septic shock.

M3 - SCORING: Zeitschriftenaufsatz

VL - 48

SP - 1297-1302, 1304

JO - INTERNIST

JF - INTERNIST

SN - 0020-9554

IS - 11

M1 - 11

ER -